Recall D-0239-2023
Description: THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/HYDROXYCOBAL 25MG/25MG/25MG/25MG/25MG/20MG/ML (3ML VIAL) INJECTABLE THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/METHYLFOLATE/METHYLCOBAL 10MG/2.5MG/25MG/5MG/5MG/10MG/10MG/ML (1ML VIAL) INJECTABLE THIAMINE/RIBOFLAVIN/NIACINAMIDE/DEXPANTHENOL/PYRIDOXINE 50MG/1MG/100MG/3MG/2MG/ML (30ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Recall D-0239-2023 Information
| Status | Ongoing |
| Mandated? | Voluntary: Firm initiated |
| Recall Number | D-0239-2023 |
| Event ID | 91332 |
| Distribution | Nationwide in the USA |
| Recall Reason | Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. |
| Drug Classification | Class II |
| Drug Code Info | 20230201 |
| Recall Initiation Date | 20221222 |
| Report Date | 20230201 |
| Classification Date | 20230126 |
| Address | 2936 W 17th St Erie, PA 16505-3929 United States |
| Recalling Firm | Pharmacy Innovations |
| Initial Notification | Telephone |
| Similar To |